KLK3 and cancer: According to the National Comprehensive Cancer Network (NCCN) guideline (http://www.nccn.com/cancer-guidelines.html#prostate), patients with a localized, low recurrence risk cancer (stage T1-T2a, Gleason scores ≤6, and PSA < 10 ng/mL) could be managed with active surveillance or surgery or radiation alone.